Technology in Cancer Research & Treatment,
Год журнала:
2024,
Номер
23
Опубликована: Янв. 1, 2024
Gastric
cancer
(GC)
is
a
prevalent
malignant
tumor
and
ranks
as
the
second
leading
cause
of
death
among
patients
worldwide.
Due
to
its
hidden
nature
difficulty
in
detection,
GC
has
high
incidence
poor
prognosis.
Traditional
treatment
methods
such
systemic
chemotherapy,
radiotherapy,
surgical
resection
are
commonly
used,
but
they
often
fail
achieve
satisfactory
curative
effects,
resulting
very
low
5-year
survival
rate
for
patients.
Currently,
targeted
therapy
immunotherapy
prominent
areas
research
both
domestically
internationally.
These
hold
promise
GC.
This
article
focuses
on
signaling
pathways
associated
with
development
GC,
well
recent
advancements
applications
immunotherapy.
The
aim
provide
fresh
insights
clinical
Signal Transduction and Targeted Therapy,
Год журнала:
2024,
Номер
9(1)
Опубликована: Дек. 1, 2024
Cancer
has
a
high
mortality
rate
across
the
globe,
and
tissue
biopsy
remains
gold
standard
for
tumor
diagnosis
due
to
its
level
of
laboratory
standardization,
good
consistency
results,
relatively
stable
samples,
accuracy
results.
However,
there
are
still
many
limitations
drawbacks
in
application
tumor.
The
emergence
liquid
provides
new
ideas
early
prognosis
Compared
with
biopsy,
advantages
treatment
various
types
cancer,
including
non-invasive,
quickly
so
on.
Currently,
detection
received
widely
attention.
It
is
now
undergoing
rapid
progress,
it
holds
significant
potential
future
applications.
Around
now,
biopsies
encompass
several
components
such
as
circulating
cells,
DNA,
exosomes,
microRNA,
RNA,
platelets,
endothelial
cells.
In
addition,
advances
identification
indicators
have
significantly
enhanced
possibility
utilizing
clinical
settings.
this
review,
we
will
discuss
application,
challenges
some
common
tumors
from
perspective
diverse
systems
tumors,
look
forward
development
prospects
field
cancer
treatment.
Cell Death and Disease,
Год журнала:
2025,
Номер
16(1)
Опубликована: Фев. 7, 2025
Abstract
Gastric
cancer
(GC)
remains
a
leading
cause
of
cancer-related
mortality
worldwide,
with
limited
treatment
options
in
advanced
stages.
Immunotherapy,
particularly
immune
checkpoint
inhibitors
(ICIs)
targeting
PD1/PD-L1,
has
emerged
as
promising
therapeutic
approach.
However,
significant
proportion
patients
exhibit
primary
or
acquired
resistance,
limiting
the
overall
efficacy
immunotherapy.
This
review
provides
comprehensive
analysis
mechanisms
underlying
immunotherapy
resistance
GC,
including
role
tumor
microenvironment,
dynamic
PD-L1
expression,
compensatory
activation
other
checkpoints,
and
genomic
instability.
Furthermore,
explores
GC-specific
factors
such
molecular
subtypes,
unique
evasion
mechanisms,
impact
Helicobacter
pylori
infection.
We
also
discuss
emerging
strategies
to
overcome
combination
therapies,
novel
immunotherapeutic
approaches,
personalized
based
on
genomics
microenvironment.
By
highlighting
these
key
areas,
this
aims
inform
future
research
directions
clinical
practice,
ultimately
improving
outcomes
for
GC
undergoing
Clinical and Experimental Medicine,
Год журнала:
2024,
Номер
24(1)
Опубликована: Сен. 26, 2024
Abstract
Long
non-coding
RNAs
(lncRNAs)
have
emerged
as
crucial
regulators
in
various
cellular
processes,
including
cancer
progression
and
stress
response.
Recent
studies
demonstrated
that
copper
accumulation
induces
a
unique
form
of
cell
death
known
cuproptosis,
with
lncRNAs
playing
key
role
regulating
cuproptosis-associated
pathways.
These
may
trigger
cell-specific
responses
to
stress,
presenting
new
opportunities
prognostic
markers
therapeutic
targets.
This
paper
delves
into
the
cuproptosis-mediated
cancer,
underscoring
their
potential
biomarkers
targets
for
innovative
strategies.
A
thorough
review
scientific
literature
was
conducted,
utilizing
databases
such
PubMed,
Google
Scholar,
ScienceDirect,
search
terms
like
'lncRNAs,'
'cuproptosis,'
'cancer.'
Studies
were
selected
based
on
relevance
lncRNA
regulation
cuproptosis
pathways
implications
prognosis
treatment.
The
highlights
significant
contribution
cuproptosis-related
genes
pathways,
impacting
metabolism,
mitochondrial
responses,
apoptotic
signaling.
Specific
are
breast,
lung,
liver,
ovarian,
pancreatic,
gastric
cancers.
objective
this
article
is
explore
cancers
mediated
by
cuproptosis.
Journal of Nanobiotechnology,
Год журнала:
2024,
Номер
22(1)
Опубликована: Май 16, 2024
Gastric
cancer
represents
a
highly
lethal
malignancy
with
an
elevated
mortality
rate
among
patients,
coupled
suboptimal
postoperative
survival
prognosis.
Nectin-4,
overexpressed
oncological
target
for
various
cancers,
has
been
exploited
to
create
antibody-drug
conjugates
(ADCs)
treat
solid
tumors.
However,
there
is
limited
research
on
Nectin-4
ADCs
specifically
gastric
cancer,
and
conventional
immunoglobulin
G
(IgG)-based
frequently
encounter
binding
site
barriers.
Based
the
excellent
tumor
penetration
capabilities
inherent
in
nanobodies
(Nbs),
we
developed
Nectin-4-targeting
Nb
drug
(NDCs)
treatment
of
cancer.
Drug Development Research,
Год журнала:
2025,
Номер
86(1)
Опубликована: Янв. 20, 2025
ABSTRACT
Chemotherapy
is
an
effective
treatment
for
gastric
cancer.
However,
many
patients
develop
resistance
to
chemotherapeutic
agents
during
clinical
treatment.
LncRNA
CCAT1
has
recently
been
shown
influence
cellular
specific
drugs,
but
its
role
in
cancer
remains
underexplored.
This
study
aims
investigate
the
of
cisplatin
cells
and
potential
underlying
mechanisms.
Gastric
cell
lines
with
acquired
were
established.
The
expression
was
assessed
both
cisplatin‐sensitive
cisplatin‐resistant
AGS
lines.
knocked
down
AGS/DDP
cells,
changes
IC50
values
measured
using
Cell
Counting
Kit‐8
(CCK‐8)
assay.
Apoptosis
evaluated
by
flow
cytometry.
Additionally,
Western
blotting
employed
measure
levels
PI3K/AKT/mTOR
signaling
pathway
proteins
apoptosis‐related
interference
control
groups.
RT‐qPCR
results
indicated
that
significantly
elevated
compared
non‐resistant
cells.
Similarly,
CCK‐8
assay
demonstrated
knocking
resistant
increased
their
sensitivity
Flow
cytometry
blot
further
confirmed
silencing
promoted
apoptosis
these
higher
sensitive
counterparts,
resulted
reduced
proteins.
In
conclusion,
above
studies
induced
Current Issues in Molecular Biology,
Год журнала:
2025,
Номер
47(2), С. 69 - 69
Опубликована: Янв. 21, 2025
Photodynamic
therapy
is
a
non-ionizing
radiation
treatment
that
utilizes
photosensitizer
in
combination
with
light
to
produce
singlet
oxygen.
This
oxygen
induces
anti-cancer
effects
by
causing
apoptotic,
necrotic,
or
autophagic
cell
death
tumor
cells.
Currently,
photodynamic
employed
oncology
treat
various
cancers.
In
the
presence
of
oxygen,
this
non-invasive
approach
leads
direct
death,
damage
microvasculature,
and
induction
local
inflammatory
response.
These
allow
be
effective
treating
early-stage
tumors,
extending
survival
cases
where
surgery
not
feasible,
significantly
improving
quality
life.
paper,
we
provide
state
art
on
cytomolecular
mechanisms
associated
pathways
involved
therapy.
By
integrating
these
mechanistic
insights
most
recent
advancements
nanotechnology,
phototherapeutic
has
potential
become
prevalent
option
within
conventional
cancer
therapies,
enhancing
its
application
precision
medicine.
Abstract
Nonprogrammed
cell
death
(NPCD)
and
programmed
(PCD)
are
two
types
of
death.
Cell
is
significantly
linked
to
tumor
development,
medication
resistance,
cancer
recurrence,
metastatic
dissemination.
Therefore,
a
comprehensive
understanding
essential
for
the
treatment
cancer.
Pyroptosis
kind
PCD
distinct
from
autophagy
apoptosis
in
terms
structure
function
cells.
The
defining
features
pyroptosis
include
release
an
inflammatory
cascade
reaction
expulsion
lysosomes,
mediators,
other
cellular
substances
within
cell.
Additionally,
it
displays
variations
osmotic
pressure
both
outside
Pyroptosis,
as
evidenced
by
growing
body
research,
critical
controlling
development
diseases
In
this
paper,
we
reviewed
current
level
knowledge
on
mechanism
inflammasomes
their
connection
diseases.
This
article
presents
theoretical
framework
investigating
potential
therapeutic
targets
diseases,
overcoming
establishing
nanomedicines
associated
with
pyroptosis,
developing
risk
prediction
models
refractory
Given
link
between
emergence
pyroptosis‐targeted
treatments
may
be
cutting‐edge
strategy.
The American Journal of Gastroenterology,
Год журнала:
2023,
Номер
119(3), С. 454 - 467
Опубликована: Окт. 6, 2023
INTRODUCTION:
Gastric
cancer
is
a
significant
global
health
concern,
ranking
as
the
fifth
most
common
worldwide
and
third
leading
cause
of
cancer-related
mortality.
While
improvements
in
awareness
medical
technology
have
contributed
to
decline
incidence
gastric
many
countries,
rate
adolescents
young
adults
(GCAYA)
has
shown
an
upward
trend.
Timely
effective
strategies
for
screening,
detection,
treatment
are
crucial
managing
burden
GCAYA
optimizing
allocation
resources.
To
this
end,
our
study
aimed
examine
distribution
across
different
factors
at
global,
regional,
national
levels
between
1990
2019.
By
identifying
analyzing
these
factors,
we
can
better
inform
efforts
combat
growing
challenge.
METHODS:
This
used
data
from
Global
Burden
Disease
database
analyze
incidence,
mortality,
disability-adjusted
life
years
(DALY)
The
age-standardized
(ASIR),
mortality
rate,
DALY
(ASDR)
were
summarized
presented
visually
intuitive
manner
levels.
In
addition,
calculated
estimated
annual
percentage
change
each
indicator
globally,
regionally,
nationally
displayed
results.
Furthermore,
conducted
age-based
analysis
with
cancer,
comparing
age
composition
deaths
patients
For
sake
brevity,
will
use
abbreviation
refer
among
throughout
remainder
article.
RESULTS:
From
2019,
slightly
increased
globally.
number
newly
diagnosed
cases
rose
47,932
(95%
uncertainty
interval
44,592.9–51,005.7)
49,007
(45,007.7–53,078.1)
while
decreased
35,270
(32,579–37,678.5)
27,895
(25,710.9–30,240.4).
ASIR
showed
declining
trend,
decreasing
22.4
21.2–23.6)
per
100,000
15.6
(14.1–17.2)
also
20.5
(19.2–21.6)
11.9
(10.8–12.8)
ASDR
493.4
(463.7–523.7)
268.4
(245.5–290.6)
male
higher
than
those
female
adults.
was
2.1
times
that
individuals
(368.9
[328.2–410.3]
vs
178.2
[160.5–196.9]),
1.1
(14,971.6
[13,643.3–16,520.5]
12,923.6
[11,550.3–14,339]),
(841,920.5
[766,655.5–927,598.8]
731,976.3
[653,421–814,242.8]).
regions
high-middle
middle
sociodemographic
index
countries.
198
countries
territories
Republic
Korea
showing
greatest
decrease
1,360.5
(1,300.3–51,416.5)
298.7
(270.1–328.4)
−5.14
confidence
−7.23
–2.99).
age,
highest
proportion
being
35–39
group.
both
death
mainly
concentrated
group,
accounting
approximately
half
total
population.
DISCUSSION:
past
30
years,
although
new
population
growth,
overall
disease
indicates
progress
diagnosis,
treatment,
education,
efforts.
However,
remains
uneven
terms
sex,
development
level,
region,
country.
address
challenges,
authorities
should
take
appropriate
measures
such
screening
programs,
strengthening
individuals,
enhancing
prevention
control
improving
infrastructure
care
resources
developing
promoting
international
cooperation,
implementing
tailored
measures.